Skye Bioscience, Inc. (SKYE)
Skye Bioscience, Inc., a biopharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. The company's lead product candidate is SBI-100, which is in Phase I trials for the treatment of glaucoma and ocular hypertension. It is also developing SBI-200 that is in preclinical trials to treat and manage various eye diseases, including uveitis, dry eye syndrome, macular degeneration and diabetic retinopathy. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. was founded in 2012 and is headquartered in San Diego, California.
$177.18M
9.00
San Diego, CA
Jun 01, 2021
-1.62
$-3.60
0.06
0.19
0.00%
-70.48
0.02
-200.82
0.00
0.13
-992.56%
470.62%
Similar stocks (15)
Revolution Medicines, Inc.
RVMD
Stoke Therapeutics, Inc.
STOK
Larimar Therapeutics, Inc.
LRMR
Alector, Inc.
ALEC
Monte Rosa Therapeutics, Inc.
GLUE
Black Diamond Therapeutics, Inc.
BDTX
Cabaletta Bio, Inc.
CABA
Vaxart, Inc.
VXRT
Passage Bio, Inc.
PASG
Jaguar Health, Inc.
JAGX
Silo Pharma, Inc.
SILO
ProtoKinetix, Incorporated
PKTX
Tonix Pharmaceuticals Holding Corp.
TNXP
VBI Vaccines Inc.
VBIV
Neutra Corp.
NTRR
ETF Exposure (19)
AdvisorShares Pure Cannabis ETF
YOLO
1.03%
iShares Micro-Cap ETF
IWC
0.02753%
Vanguard Russell 2000 Value Index Fund
VTWV
0.01%
iShares Russell 2000 Value ETF
IWN
0.0068%
iShares Russell 2000 ETF
IWM
0.00411%
ProShares Ultra Russell2000
UWM
0.001545662750486867%
iShares Russell 2000 Growth ETF
IWO
0.00125%
ProShares UltraPro Russell2000
URTY
7.615698444346008e-4%
ProShares Hedge Replication ETF
HDG
6.527201411771194e-4%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Russell 2000 Growth Index Fund
VTWG
0%
Vanguard Russell 2000 Index Fund
VTWO
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (15)
Revolution Medicines, Inc.
RVMD
Stoke Therapeutics, Inc.
STOK
Larimar Therapeutics, Inc.
LRMR
Alector, Inc.
ALEC
Monte Rosa Therapeutics, Inc.
GLUE
Black Diamond Therapeutics, Inc.
BDTX
Cabaletta Bio, Inc.
CABA
Vaxart, Inc.
VXRT
Passage Bio, Inc.
PASG
Jaguar Health, Inc.
JAGX
Silo Pharma, Inc.
SILO
ProtoKinetix, Incorporated
PKTX
Tonix Pharmaceuticals Holding Corp.
TNXP
VBI Vaccines Inc.
VBIV
Neutra Corp.
NTRR
ETF Exposure (19)
AdvisorShares Pure Cannabis ETF
YOLO
1.03%
iShares Micro-Cap ETF
IWC
0.02753%
Vanguard Russell 2000 Value Index Fund
VTWV
0.01%
iShares Russell 2000 Value ETF
IWN
0.0068%
iShares Russell 2000 ETF
IWM
0.00411%
ProShares Ultra Russell2000
UWM
0.001545662750486867%
iShares Russell 2000 Growth ETF
IWO
0.00125%
ProShares UltraPro Russell2000
URTY
7.615698444346008e-4%
ProShares Hedge Replication ETF
HDG
6.527201411771194e-4%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Russell 2000 Growth Index Fund
VTWG
0%
Vanguard Russell 2000 Index Fund
VTWO
0%
Vanguard Extended Market Index Fund
VXF
0%